Compare MDGL & ROKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDGL | ROKU |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 14.4B |
| IPO Year | 2005 | 2017 |
| Metric | MDGL | ROKU |
|---|---|---|
| Price | $520.16 | $102.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $674.45 | $123.26 |
| AVG Volume (30 Days) | 349.8K | ★ 2.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.32 | ★ 166.29 |
| EPS | N/A | ★ 0.59 |
| Revenue | $180,133,000.00 | ★ $4,737,251,000.00 |
| Revenue This Year | $58.39 | $18.55 |
| Revenue Next Year | $47.10 | $12.14 |
| P/E Ratio | ★ N/A | $169.61 |
| Revenue Growth | N/A | ★ 15.18 |
| 52 Week Low | $265.00 | $57.01 |
| 52 Week High | $615.00 | $116.66 |
| Indicator | MDGL | ROKU |
|---|---|---|
| Relative Strength Index (RSI) | 62.15 | 61.20 |
| Support Level | $411.87 | $91.83 |
| Resistance Level | $610.00 | $107.49 |
| Average True Range (ATR) | 26.99 | 4.71 |
| MACD | 3.75 | 1.02 |
| Stochastic Oscillator | 64.35 | 85.17 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 145 billion streaming hours in 2025. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.